
apr pm et
summari lead consum product compani global tissu person care health care
brand includ huggi pull-up kotex depend kleenex scott
price-to-earnings oper ep
risk assess reflect gener static demand
household person care product
usual significantli affect chang
economi geopolit factor
past perform indic futur perform reli upon
analysi prepar equiti analyst
apr pm stock trade
target price recent
chang highlight
section stock report updat
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
target price
ep estim
compar ten-year forward averag
price-to-earnings trim ep
estim rais
report oper ep vs
consensu sale increas
growth consum tissu aid
volum increas growth
driven mostli currenc
tailwind adjust gross margin fell
higher pulp cost inflat
raw materi continu act
headwind see stabl margin
remaind cost
save program well restructur
initi gain traction second half
year see sale growth
aid modest price increas
posit impact currenc
jul ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview best known brand kleenex scott huggi kotex
sell consum product countri oper broadli diversifi
enterpris made major transit begin earli transform global
consum product compani compani develop health care busi
acquisit technol medic product ballard medic product safeskin corp reflect
strateg acquisit strateg divestitur sinc becom lead global
manufactur tissu person care health care product manufactur countri
classifi busi three report global segment sale
consum tissu k-c profession singl largest custom
account net sale
corpor strategi introduc new strateg plan call global busi
gbp involv priorit growth opportun appli greater financi disciplin
global oper compani plan continu execut global busi plan annual
goal establish gbp top-lin growth ep growth mid- high-singl digit
oper margin improv basi point capit spend net sale
improv basi point dividend increas line ep growth also
gbp capit alloc focus target expans activ increas emphasi
innov cost reduct
januari announc global restructur program reduc structur
cost base streamlin simplifi manufactur suppli chain overhead organ
restructur expect complet end total cost anticip billion
billion pre-tax billion billion tax cost expect million
billion addit compani expect incur increment capit spend
implement restructur workforc reduct expect rang
restructur expect impact busi segment organ major geographi
support margin improv target made cost reduct system part
busi model compani focus reduc cost everywher program aim
promot best practic regard cost work capit manag across compani
realiz save well streamlin manufactur administr oper
primarili north american europ million million million
million million million compani achiev
million save
impact signific develop novemb complet tax free spin-off
health care busi known halyard health hyh nr manag indic strateg
fit growth prioriti busi chang time move would allow
health optim perform flexibl pursu value-cr opportun
also expect abl sharpen focu consum non-health care profession
brand sharehold receiv one share hyh common stock everi eight share
common stock held close trade octob record date spin-off
initi organiz restructur order improv effici off-set impact
strand overhead cost result spin-off health care busi octob
compani complet restructur total cost million tax million
pre-tax cumul pre-tax save million million end
financi trend net sale grew follow declin reflect
unfavor impact chang foreign currenc exchang rate net sale fell
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli under-valued
neutral sinc februari technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
howev actual magnitud impact
depend market manufactur
sell actual currenc movement
extent currenc hedg
year date march
versu rise
 household product index
increas compar rise
 note procter
 gambl weight
base index
five-year market price perform apr
note sector sub-industri inform base
past perform indic futur perform
reli upon
neutral fundament outlook
household product sub-industri next
month consum confid continu trend
higher thank part modest improv
employ market expect wage growth
improv slowli remain low level
think abil compani fend
market share gain supplier lower-pr
product depend part market
support provid scope
success product innov
market brand compani vie
market share privat label store brand
product view competit well
leverag larg retail often
limit gener price increas household
product howev expect
reduct cost see
opportun margin expans raw
materi use household product
pulp resin number compani continu
look way oper effici
part off-set pressur higher input
household product sub-industri remain
competit view given matur
develop countri numer
compani vy captur market share
chang lifestyl develop
intern market like provid
secular growth opportun
calcul expect emerg market see
rise demand packag product
consum could previous afford
notwithstand slight deceler
econom growth rate certain market
past year
multi-national compani expect weaker
 dollar boost foreign sale
sale translat dollar
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
fx set ep adjust ep vs
estim organ sale growth line estim support
sequenti improv volum despit unfavor price/mix
see intens price competit emerg market limit sale growth
expect margin benefit acceler cost cut volum leverag
et cfra keep hold recommend share
kimberly-clark corpor lower target
price price-to-earnings in-lin kmb averag
ep estim decreas ep
estim ep vs
estim see valuat ep growth hurt unfavor constant
currenc sale growth trend across busi segment reflect difficult
comparison increas competit howev still think growth
achiev continu low input cost benefit cost
cut restructur /j agnes
analyst research note compani news
lower target price
ep estim compar ten-year forward averag price-to-earnings
trim ep estim rais
report oper ep
vs consensu sale increas growth
consum tissu aid volum increas growth person
driven mostli currenc tailwind adjust gross margin fell
higher pulp cost inflat raw materi continu act
headwind see stabl margin remaind forc
cost save program well restructur initi gain traction
second half year see sale growth aid
modest price increas posit impact currenc movement
corpor keep target
ep estim compar five-year forward averag price-to-earnings
balanc slower sale growth outlook expect margin
expans driven restructur effort rais ep estim
set report oper ep
vs consensu plan cut workforc
close ten factori exit sell
low margin busi effort cut cost see posit
kimberly-clark corpor keep target
price-to-earnings near mid-point rang
forward ep estim adjust ep vs
estim organ sale slightli posit line
estim volum growth off-set lower price
intens competit environ yet see sale support comp eas
margin widen expect cost save reduc
market research spend see margin benefit somewhat
restrict rise input cost /joseph agnes
et cfra keep hold recommend share
trim target price
appli price-to-earnings line averag forward
ep estim lower ep estim
ep vs
estim organ growth fell expect drag
declin consum product reflect categori soft less promot
shipment increas competit margin pressur rise input
cost price competit expect increas focu cost cut
et cfra keep hold opinion share
corpor keep target price-to-earnings
line kmb averag ep estim
trim ep estim ep
vs estim lower expect tax
rate organ net sale declin wider expect north american
result hurt categori soft increas competit reduc
promot despit growth develop emerg market see
margin benefit cost save partli off-set rise input cost inflat
kimberly-clark corpor rais target
price appli price-to-earnings line kmb
averag ep estim cut unfavor
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd fiscal year analyst estim
earn per share grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
